$PLL
Piedmont Lithium Inc.

2021 Q2 Form 10-K Financial Statement

#000114036121032488 Filed on September 24, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $9.345M $11.64M $3.598M
YoY Change 159.72% 223.37%
% of Gross Profit
Research & Development $10.38M $8.941M $2.955M
YoY Change 251.3% 202.61%
% of Gross Profit
Depreciation & Amortization $1.376K $11.59K $13.25K
YoY Change -89.62% -12.53%
% of Gross Profit
Operating Expenses $19.74M $20.58M $6.566M
YoY Change 200.58% 213.51%
Operating Profit -$7.479M -$19.74M
YoY Change 200.58%
Interest Expense -$63.22K -$267.9K $686.8K
YoY Change -109.2% -596.44%
% of Operating Profit
Other Income/Expense, Net -$193.3K
YoY Change -128.14%
Pretax Income -$7.600M -$19.93M -$5.879M
YoY Change 29.27% 238.98%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.633M -$19.99M -$5.879M
YoY Change 29.83% 240.08%
Net Earnings / Revenue
Basic Earnings Per Share -$0.48 -$1.48
Diluted Earnings Per Share -$0.48 -$1.48 -$709.7K
COMMON SHARES
Basic Shares Outstanding 15.75M shares 13.55M
Diluted Shares Outstanding 15.75M shares 13.55M

Balance Sheet

Concept 2021 Q2 2021 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $142.7M $64.24M $18.86M
YoY Change 656.49% 240.69%
Cash & Equivalents $142.7M $64.24M $18.86M
Short-Term Investments
Other Short-Term Assets $1.251M $2.515M $58.98K
YoY Change 2021.6% 4163.48%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $143.9M $66.76M $18.92M
YoY Change 660.74% 252.93%
LONG-TERM ASSETS
Property, Plant & Equipment $725.9K $40.12M $717.4K
YoY Change 1.18% 360.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $16.26M $58.87M $0.00
YoY Change
Other Assets $222.7K $4.500M $29.91K
YoY Change 644.66% 14945.8%
Total Long-Term Assets $43.95M $103.5M $8.737M
YoY Change 403.02% 1084.51%
TOTAL ASSETS
Total Short-Term Assets $143.9M $66.76M $18.92M
Total Long-Term Assets $43.95M $103.5M $8.737M
Total Assets $187.9M $170.2M $27.65M
YoY Change 579.32% 515.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.562M $1.263M $791.3K
YoY Change 223.77% 59.59%
Accrued Expenses $2.397M $5.485M $441.3K
YoY Change 443.26% 850.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.085M $762.2K $577.6K
YoY Change 87.88% 31.96%
Total Short-Term Liabilities $6.215M $7.550M $1.946M
YoY Change 219.34% 287.97%
LONG-TERM LIABILITIES
Long-Term Debt $1.226M $0.00 $1.740M
YoY Change -29.52% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $29.91K
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $1.226M $0.00 $1.770M
YoY Change -30.71% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.215M $7.550M $1.946M
Total Long-Term Liabilities $1.226M $0.00 $1.770M
Total Liabilities $7.441M $8.464M $3.850M
YoY Change 93.29% 119.87%
SHAREHOLDERS EQUITY
Retained Earnings -$71.30M -$51.59M
YoY Change 38.21%
Common Stock $1.550K $1.025K
YoY Change 51.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $180.4M $161.8M $23.80M
YoY Change
Total Liabilities & Shareholders Equity $187.9M $170.2M $27.65M
YoY Change 579.32% 515.66%

Cashflow Statement

Concept 2021 Q2 2021 2020 Q2
OPERATING ACTIVITIES
Net Income -$7.633M -$19.99M -$5.879M
YoY Change 29.83% 240.08%
Depreciation, Depletion And Amortization $1.376K $11.59K $13.25K
YoY Change -89.62% -12.53%
Cash From Operating Activities -$16.26M -$16.26M -$6.332M
YoY Change 156.74% 156.74%
INVESTING ACTIVITIES
Capital Expenditures -$18.21M $20.04K -$3.452M
YoY Change 427.41% -97.16%
Acquisitions
YoY Change
Other Investing Activities -$16.36M -$47.91M $0.00
YoY Change
Cash From Investing Activities -$34.57M -$34.57M -$3.452M
YoY Change 901.25% 901.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $175.0M
YoY Change 596.82%
Debt Paid & Issued, Net $695.6K
YoY Change 78.15%
Cash From Financing Activities 174.6M 174.6M 24.72M
YoY Change 606.42% 606.42%
NET CHANGE
Cash From Operating Activities -16.26M -16.26M -6.332M
Cash From Investing Activities -34.57M -34.57M -3.452M
Cash From Financing Activities 174.6M 174.6M 24.72M
Net Change In Cash 123.8M 123.8M 14.93M
YoY Change 728.94% 728.94%
FREE CASH FLOW
Cash From Operating Activities -$16.26M -$16.26M -$6.332M
Capital Expenditures -$18.21M $20.04K -$3.452M
Free Cash Flow $1.950M -$16.28M -$2.880M
YoY Change -167.71% 131.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-827853
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1232528
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-796565
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35069
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4959031
CY2020Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
791264
CY2021Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2561834
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
441264
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23480
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
252571659
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2397197
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76187975
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
470939
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1319372
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1319372
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
470938
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
489249
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
586250
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
1025
CY2021Q2 us-gaap Assets
Assets
187851629
CY2020Q2 us-gaap Assets
Assets
27652958
CY2020Q2 us-gaap Assets Current
AssetsCurrent
18916068
CY2021Q2 us-gaap Assets Current
AssetsCurrent
143902970
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14933998
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
123794560
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18857088
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142651648
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4432150
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15764533
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10356762
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15764533
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10356762
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1550
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6378551
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
72006
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
285808
CY2020Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
78938
CY2020Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2021Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2021Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
45102
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
78938
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20025136
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
45102
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8667950
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13399777
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
441169
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
730339
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4266906
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6039013
CY2020Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
76581
CY2021Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
39476
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8589012
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13354675
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7065740
CY2020Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
78938
CY2021Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
45102
CY2020 us-gaap Depreciation
Depreciation
13249
CY2021 us-gaap Depreciation
Depreciation
11589
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-509060
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1234622
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
141223
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
63229
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
16262498
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17601419
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
299965
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
632832
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
74620
CY2021Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.457
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8861454
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3440161
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5879152
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19929222
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5424724
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5879151
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19993848
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-454427
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-13801
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-22160
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1523272
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4765663
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-338078
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-985983
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2392429
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-64626
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4198708
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
168006
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-144096
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-118555
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1079811
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3726503
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1385134
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
29736
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-267886
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
53961
CY2020 us-gaap Interest Paid Net
InterestPaidNet
157271
CY2021 us-gaap Interest Paid Net
InterestPaidNet
289125
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-5879152
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
147506
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
147506
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7071
CY2020Q2 us-gaap Liabilities
Liabilities
3849662
CY2021Q2 us-gaap Liabilities
Liabilities
7440918
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187851629
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27652958
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6214514
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1946051
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
577576
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1085142
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1740042
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1226404
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24718553
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
174617607
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6332301
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16257254
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34565793
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3452254
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-19993848
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29906
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
139797
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
165456
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
156456
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P22M29D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11M2D
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1251322
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
269610
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
222698
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29906
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-31288
CY2020 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
0
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
140435
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
135947
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
133663
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
152251
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
165817
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
268610
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
140435
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-6565945
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-19735956
CY2020Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4292799
CY2021Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6074775
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-499399
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
58980
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29906
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-499399
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31288
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-499399
CY2020 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
2747784
CY2021 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
17898705
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16358412
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20035
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
704471
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25108987
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
174964132
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
349047
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
717417
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
725863
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
740897
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
760932
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
391549
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14921
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
695572
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
390434
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51589139
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71334645
CY2021 us-gaap Sublease Income
SubleaseIncome
120752
CY2020 us-gaap Sublease Income
SubleaseIncome
29906
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1319372
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
470939
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
78583
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
32673
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
349047
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
174964132
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25108988
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
180410711
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
23803296
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
4598715
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-weight: bold;">Use of Estimates</div><div>&#160;</div><div style="color: rgb(0, 0, 0);">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, recoverability of long-lived assets, recognition of tax losses, depreciation, depletion, and amortization.</div><div><br /></div><div>The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company&#8217;s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</div></div>
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13551150
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8283567
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13551150
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8283567
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021 dei Entity Registrant Name
EntityRegistrantName
Piedmont Lithium Inc.
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001728205
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
339661709
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21514715
CY2021Q2 pll Exploration And Evaluation Assets
ExplorationAndEvaluationAssets
26597803
CY2020Q2 pll Exploration And Evaluation Assets
ExplorationAndEvaluationAssets
7720957
CY2019Q2 pll Exploration And Evaluation Assets
ExplorationAndEvaluationAssets
2265121
CY2021 pll Exploration And Evaluation Expense
ExplorationAndEvaluationExpense
10874502
CY2020 pll Exploration And Evaluation Expense
ExplorationAndEvaluationExpense
3125784
CY2021 pll Payments To Acquire Land Seller Financed Loans
PaymentsToAcquireLandSellerFinancedLoans
978141
CY2020 pll Payments To Acquire Land Seller Financed Loans
PaymentsToAcquireLandSellerFinancedLoans
2708052
CY2021 pll Minimum Realized Income Tax Benefit Percent
MinimumRealizedIncomeTaxBenefitPercent
0.5
CY2021 pll Share Based Compensation Arrangement By Share Based Payment Award Options Value Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsValueExpirationsInPeriod
0
CY2020 pll Share Based Compensation Arrangement By Share Based Payment Award Options Value Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsValueExpirationsInPeriod
0
CY2021 pll Stock Issued During Period Value Conversion Of Performance Rights
StockIssuedDuringPeriodValueConversionOfPerformanceRights
0
CY2020 pll Stock Issued During Period Value Conversion Of Performance Rights
StockIssuedDuringPeriodValueConversionOfPerformanceRights
0
CY2021 pll Stock Issued During Period Value Stock Options Exercised Cashless
StockIssuedDuringPeriodValueStockOptionsExercisedCashless
0
CY2021 pll Payments For Exploration And Evaluation Assets
PaymentsForExplorationAndEvaluationAssets
18187346
CY2020 pll Payments For Exploration And Evaluation Assets
PaymentsForExplorationAndEvaluationAssets
2747783
CY2020 pll Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
122759
CY2021 pll Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
143734
CY2020 pll Noncash Acquisitions Of Exploration And Evaluation Assets Financed By Seller
NoncashAcquisitionsOfExplorationAndEvaluationAssetsFinancedBySeller
2708052
CY2021 pll Noncash Acquisitions Of Exploration And Evaluation Assets Financed By Seller
NoncashAcquisitionsOfExplorationAndEvaluationAssetsFinancedBySeller
689500
CY2021Q2 pll Number Of Sublease Properties
NumberOfSubleaseProperties
1
CY2020Q2 pll Deferred Tax Assets Tax Deferred Expense Exploration And Evaluation Expenditures
DeferredTaxAssetsTaxDeferredExpenseExplorationAndEvaluationExpenditures
3811288
CY2021Q2 pll Deferred Tax Assets Tax Deferred Expense Exploration And Evaluation Expenditures
DeferredTaxAssetsTaxDeferredExpenseExplorationAndEvaluationExpenditures
6305141
CY2020 pll Valuation Allowance Deferred Tax Asset Deductions
ValuationAllowanceDeferredTaxAssetDeductions
0
CY2021 pll Valuation Allowance Deferred Tax Asset Deductions
ValuationAllowanceDeferredTaxAssetDeductions
0
CY2021 pll Valuation Allowance Deferred Tax Asset Additions
ValuationAllowanceDeferredTaxAssetAdditions
4765663
CY2020 pll Valuation Allowance Deferred Tax Asset Additions
ValuationAllowanceDeferredTaxAssetAdditions
1523272

Files In Submission

Name View Source Status
0001140361-21-032488-index-headers.html Edgar Link pending
0001140361-21-032488-index.html Edgar Link pending
0001140361-21-032488.txt Edgar Link pending
0001140361-21-032488-xbrl.zip Edgar Link pending
brhc10028369_10k.htm Edgar Link pending
brhc10028369_ex10-2.htm Edgar Link pending
brhc10028369_ex10-4.htm Edgar Link pending
brhc10028369_ex10-5.htm Edgar Link pending
brhc10028369_ex21-1.htm Edgar Link pending
brhc10028369_ex23-1.htm Edgar Link pending
brhc10028369_ex31-1.htm Edgar Link pending
brhc10028369_ex31-2.htm Edgar Link pending
brhc10028369_ex32-1.htm Edgar Link pending
brhc10028369_ex32-2.htm Edgar Link pending
brhc10028369_ex4-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image7.jpg Edgar Link pending
pll-20210630.xml Edgar Link completed
pll-20210630.xsd Edgar Link pending
pll-20210630_cal.xml Edgar Link unprocessable
pll-20210630_def.xml Edgar Link unprocessable
pll-20210630_lab.xml Edgar Link unprocessable
pll-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending